Global Bioenergies (GBE) has raised €6.5m in a private placement, lifting its gross cash to €16m to fund its isobutene process development and commercial roll-out. This should fund the company well into 2017 and even cover some increased outlay for more aggressive commercial development. Our updated model results in a fair value range of €32-59 per share (from €35-63).
29 Jan 2016
Funding growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Funding growth
Global Bioenergies SA (ALGBE:PAR) | 0 0 1.6% | Mkt Cap: 77.3m
- Published:
29 Jan 2016 -
Author:
Catharina Hillenbrand-Saponar -
Pages:
4
Global Bioenergies (GBE) has raised €6.5m in a private placement, lifting its gross cash to €16m to fund its isobutene process development and commercial roll-out. This should fund the company well into 2017 and even cover some increased outlay for more aggressive commercial development. Our updated model results in a fair value range of €32-59 per share (from €35-63).